Last Price
195.60
Today's Change
+8.38 (4.47%)
Day's Change
185.37 - 195.67
Trading Volume
1,491,057
Market Cap
16 Billion
Shares Outstanding
82 Million
Avg Volume
1,073,193
Avg Price (50 Days)
264.80
Avg Price (200 Days)
303.48
PE Ratio
21.76
EPS
8.99
Earnings Announcement
19-Feb-2025
Previous Close
187.22
Open
186.79
Day's Range
185.375 - 195.675
Year Range
183.38 - 347.72
Trading Volume
1,491,057
1 Day Change
4.48%
5 Day Change
-4.12%
1 Month Change
-34.30%
3 Month Change
-39.80%
6 Month Change
-37.85%
Ytd Change
-30.34%
1 Year Change
-27.56%
3 Year Change
-31.66%
5 Year Change
25.84%
10 Year Change
264.11%
Max Change
2975.77%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.